- Category Marryalyan
- DATE 25 Feb 2025
Cancer Symptom Trials and Palliative Care Clinical Studies Collaborative
February 2025

PaCCSC & CST Research Forum 2025
The Science behind the Art of care: Clinical trials in cancer symptoms and palliative care
27-28 March 2025 | ICC, Sydney
We’re excited to invite you to the PaCCSC & CST Research Forum 2025, where we’ll explore the scientific foundations that inform best practices in cancer symptom management and palliative care.
We are thrilled to welcome three international keynote speakers to the forum:
-
- Professor William Dale, Geriatric Medicine, USA
- Professor Catherine Walshe, Palliative Care, UK
- Professor Steve Pantilat, Palliative Care, USA
This event is for researchers, healthcare professionals and consumers with experience or interest in palliative care or cancer symptom management research.
We invite you to take this opportunity to connect with leading experts and build your networks in palliative care and cancer symptom management research.
Register now
Email enquiries to [email protected]
Expressions of interest – Join a PaCCSC & CST Symptom Node Subcommittee
Help shape the future of palliative care and cancer symptom management
Researchers, clinicians and consumers with an interest in palliative care and/or cancer symptom management are invited to express interest in joining a PaCCSC & CST Symptom Node Subcommittee
Our seven Symptom Node Subcommittees (SNSCs) each lead a dedicated research program focused on a specific symptom:
-
- Appetite and cachexia
- Breathlessness and sleep
- Cognitive and neurological disorders
- Fatigue
- Gut dysfunction
- Nausea
- Pain
This is an excellent opportunity to extend your personal research profile as part of a collaborative research team, while contributing to better quality-of-life outcomes for patients and families.
Hannah Wardill, Chair, Gut Dysfunction Symptom Node SubCommittee
We'd love to hear from you if:
-
- you have an interest in collaborating on a research program investigating one or more symptoms and its impacts on people with cancer or in palliative care
- have capacity to be committed and engaged to support the work of the node.
Commitment
Term of membership: two years Meeting schedule: quarterly 1-hour meetings. For questions or to express interest in joining an SNSC, please email [email protected]
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Participating in the program provides an opportunity to develop the capacity and research capabilities of you and your staff who may not otherwise have the opportunity to engage in research.
Adult series
Pancreatic Enzyme Replacement Therapy (PERT) for pancreatic cancer – series 53
The PERT for pancreatic cancer Rapid series is open for recruitment. This study aims to explore clinicians’ prescribing practices and evaluate the efficacy and safety of PERT for people with pancreatic cancer. PERT is a biological medication administered in capsule form to treat pancreatic exocrine insufficient (PEI) as it aids digestion.
Research suggests that PERT is well tolerated and helps with symptom management, weight stabilisations, toleration of oncology treatments and even survival. However, published literature indicates that prescribing rates are low globally among clinicians treating people with pancreatic cancer.
Paediatric series
Ketamine for cancer-related mucositis pain – series 42
In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.
Ketamine is widely used for paediatric general and regional anaesthesia, procedural sedation, as an adjunct to opioid analgesia, and as a low-dose continuous infusion for the treatment of both acute and complex pain.
If you can help us to collect data to improve the available evidence about the effectiveness of ketamine for children with cancer-related mucositis pain, please get in touch.
To express interest in participating in these series or to learn more about other series in the IMPACCT Rapid Program, visit uts.edu.au/rapid or email [email protected]
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology yesterday
COSA Nutrition Group & Dietitians Australia Oncology Interest Group are hosting a free webinar, Tue 3 June, featuring four projects to enhance the nutritional status of patients undergoing treatment for various cancers. bit.ly/4dJqssp Register bit.ly/4kr6Laz
Read More >
COSAoncology 9 days ago
Don’t miss out on a saving! Join or renew by 16 May 2025 to take advantage of 2024 COSA membership rates before prices increase for 2025. bit.ly/3hXsDLm
Read More >
COSAoncology 15 days ago
COSA membership renewals are open for 2025/26! All members can take advantage of a saving if you renew manually by 16 May 2025. Don’t miss out: bit.ly/4cI0nc3
Read More >
COSAoncology 17 days ago
Thanks to @TROGfightcancer for renewing as a COSA Associated organisation. TROG members are invited to take advantage of discounted COSA membership: bit.ly/3s5mOC6
Read More >
COSAoncology 17 days ago
Did you know #OSWANZ members can join COSA at a discounted rate? Thank you to Oncology Social Work Australia & New Zealand for continuing Affiliated organisation membership with COSA! bit.ly/3s5mOC6
Read More >
COSAoncology 21 days ago
Thank you, @dietitiansaus for continuing your COSA Associated organisation membership! DA members are invited to join or renew with COSA at discounted rates: bit.ly/3s5mOC6
Read More >
COSAoncology 21 days ago
Did you know ANZHNCS members can join COSA at a discounted rate? Thank you to @anzhncs for continuing Affiliated organisation membership with COSA. bit.ly/3s5mOC6
Read More >
COSAoncology 21 days ago
Cancer pharmacists will gather in Melbourne this weekend for the COSA CPG Clinical Practice Course. There are streams for those with a basic knowledge and those with an advanced clinical level in oncology and haematology pharmacy practice.
Read More >
COSAoncology 22 days ago
Our April member newsletter is out now with Group updates, new resources, journal articles, oncology events and more. Check your inbox or view the COSA eNews online at bit.ly/42SWNrG
Read More >
COSAoncology 22 days ago
Join or renew as a COSA member by 16 May 2025 to make a saving! For members, your renewal email is in your inbox today. bit.ly/3hXsDLm
Read More >